Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Juhan-Vague

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
La Revue Du Praticien|November 11, 1989
[Is hypofibrinolysis a risk factor of thrombosis?]I Juhan-Vague
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1990
[Fibrinolytic system and hyperinsulinism]I Juhan-Vague
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[Atheroma and antithrombotic agents]I Juhan-Vague
American Journal of Obstetrics and Gynecology|July 1, 1990
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseI Juhan-Vague, P Vague
Diabetologia|June 1, 1997
Fibrinogen, fibrinolysis and diabetes mellitus: a commentP Vague, I Juhan-Vague
Nouvelle Revue Francaise D'Hematologie|January 1, 1982
[Erythrocyte and platelet parameters and degree of control of diabetes]I Juhan-Vague, P Vague
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1995
[Dyslipidemia, lipid lowering drugs and thrombosis]P Ambrosi, I Juhan-Vague
Annals of Epidemiology|July 1, 1992
On the role of coagulation and fibrinolysis in atherosclerosisI Juhan-Vague, D Collen
Diabete & Metabolisme|May 1, 1991
Hypofibrinolysis and insulin-resistanceI Juhan-Vague, P Vague
Seminars in Thrombosis and Hemostasis|April 1, 1988
Fibrinolysis and atherosclerosisD Collen, I Juhan-Vague
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
La Revue Du Praticien|November 11, 1989
[Is hypofibrinolysis a risk factor of thrombosis?]I Juhan-Vague
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1990
[Fibrinolytic system and hyperinsulinism]I Juhan-Vague
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[Atheroma and antithrombotic agents]I Juhan-Vague
American Journal of Obstetrics and Gynecology|July 1, 1990
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular diseaseI Juhan-Vague, P Vague
Diabetologia|June 1, 1997
Fibrinogen, fibrinolysis and diabetes mellitus: a commentP Vague, I Juhan-Vague
Nouvelle Revue Francaise D'Hematologie|January 1, 1982
[Erythrocyte and platelet parameters and degree of control of diabetes]I Juhan-Vague, P Vague
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1995
[Dyslipidemia, lipid lowering drugs and thrombosis]P Ambrosi, I Juhan-Vague
Annals of Epidemiology|July 1, 1992
On the role of coagulation and fibrinolysis in atherosclerosisI Juhan-Vague, D Collen
Diabete & Metabolisme|May 1, 1991
Hypofibrinolysis and insulin-resistanceI Juhan-Vague, P Vague
Seminars in Thrombosis and Hemostasis|April 1, 1988
Fibrinolysis and atherosclerosisD Collen, I Juhan-Vague
Pageof 22